Cellectis Reaches Analyst Target Price
January 20, 2021 at 08:40 AM EST
In recent trading, shares of Cellectis SA (CLLS) have crossed above the average analyst 12-month target price of $32.17, changing hands for $33.25/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..